(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies.
Eur J Cancer
; 51(14): 1857-64, 2015 Sep.
Article
in En
| MEDLINE
| ID: mdl-26187510
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Yttrium Radioisotopes
/
Adenocarcinoma
/
Radioimmunotherapy
/
Radiopharmaceuticals
/
Deoxycytidine
/
Antibodies, Monoclonal
/
Antimetabolites, Antineoplastic
Type of study:
Clinical_trials
Limits:
Aged80
Country/Region as subject:
America do norte
Language:
En
Journal:
Eur J Cancer
Year:
2015
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom